Key regional partner for Veldona; a good start for Ainos’ out-licensing strategy. Ainos entered a strategic partnership with Taiwan Tanabe Seiyaku for Veldona in Sjogren’s syndrome.
What is covered in the Full Insight:
Introduction to Veldona and Ainos' Strategy
Partnership with Taiwan Tanabe Seiyaku
Clinical Trial Updates
Market Outlook for Sjogren's Syndrome Treatment
Prior Clinical Study Results for Veldona
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.